Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment
- PMID: 25196648
- PMCID: PMC4253499
- DOI: 10.1111/imm.12380
Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment
Abstract
Hypoxia is one of the hallmarks of the tumour microenvironment. It is the result of insufficient blood supply to support proliferating tumour cells. In response to hypoxia, the cellular machinery uses mechanisms whereby the low level of oxygen is sensed and counterbalanced by changing the transcription of numerous genes. Hypoxia-inducible factors (HIF) play a critical role in the regulation of cellular responses to hypoxia. In recent years ample evidence has indicated that HIF play a prominent role in tumour immune responses. Up-regulation of HIF1α promotes immune suppressive activity of myeloid-derived suppressive cells (MDSC) and tumour-associated macrophages (TAM) and rapid differentiation of MDSC to TAM. HIF1α does not affect MDSC differentiation to dendritic cells (DC) but instead causes DC activation. HIF inhibit effector functions of tumour-infiltrating lymphocytes. HIF1α inhibits regulatory T (Treg) cell development by switching the balance towards T helper type 17 cells. However, as a major part of Treg cell differentiation does not take place in the tumour site, a functionally more important role of HIF1α is in the promotion of Treg cell recruitment to the tumour site in response to chemokines. As a result, the presence of Treg cells inside tumours is increased. Hence, HIF play a largely negative role in the regulation of immune responses inside tumours. It appears that therapeutic strategies targeting HIF in the immune system could be beneficial for anti-tumour immune responses.
Keywords: T cells; hypoxia; hypoxia-inducible factor; macrophages; myeloid-derived suppressor cells.
© 2014 John Wiley & Sons Ltd.
Figures
Similar articles
-
Hypoxia and hypoxia-inducible factors in myeloid cell-driven host defense and tissue homeostasis.Immunobiology. 2015 Feb;220(2):305-14. doi: 10.1016/j.imbio.2014.09.009. Epub 2014 Sep 16. Immunobiology. 2015. PMID: 25439732 Review.
-
The heterogeneous immune microenvironment in breast cancer is affected by hypoxia-related genes.Immunobiology. 2014 Feb;219(2):158-65. doi: 10.1016/j.imbio.2013.09.003. Epub 2013 Sep 8. Immunobiology. 2014. PMID: 24091277
-
Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.Am J Physiol Cell Physiol. 2015 Nov 1;309(9):C569-79. doi: 10.1152/ajpcell.00207.2015. Epub 2015 Aug 26. Am J Physiol Cell Physiol. 2015. PMID: 26310815 Free PMC article. Review.
-
Hypoxia-inducible factor-1 drives divergent immunomodulatory functions in the pathogenesis of autoimmune diseases.Immunology. 2021 Sep;164(1):31-42. doi: 10.1111/imm.13335. Epub 2021 Apr 27. Immunology. 2021. PMID: 33813735 Free PMC article. Review.
-
Immune response regulation in the tumor microenvironment by hypoxia.Semin Oncol. 2015 Jun;42(3):378-86. doi: 10.1053/j.seminoncol.2015.02.009. Epub 2015 Feb 13. Semin Oncol. 2015. PMID: 25965356 Review.
Cited by
-
Hyperbaric oxygen therapy sensitizes nimustine treatment for glioma in mice.Cancer Med. 2016 Nov;5(11):3147-3155. doi: 10.1002/cam4.851. Epub 2016 Oct 13. Cancer Med. 2016. PMID: 27734611 Free PMC article.
-
The unfolded protein response in immunity and inflammation.Nat Rev Immunol. 2016 Aug;16(8):469-84. doi: 10.1038/nri.2016.62. Epub 2016 Jun 27. Nat Rev Immunol. 2016. PMID: 27346803 Free PMC article. Review.
-
Implications of single-cell immune landscape of tumor microenvironment for the colorectal cancer diagnostics and therapy.Med Oncol. 2023 Nov 11;40(12):352. doi: 10.1007/s12032-023-02226-z. Med Oncol. 2023. PMID: 37950801 Review.
-
The role of hypoxia-inducible factors in tumor angiogenesis and cell metabolism.Genes Dis. 2016 Dec 14;4(1):19-24. doi: 10.1016/j.gendis.2016.11.003. eCollection 2017 Mar. Genes Dis. 2016. PMID: 30258904 Free PMC article. Review.
-
The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanib.Expert Rev Anticancer Ther. 2019 Nov;19(11):971-991. doi: 10.1080/14737140.2019.1686979. Epub 2019 Nov 13. Expert Rev Anticancer Ther. 2019. PMID: 31665941 Free PMC article. Review.
References
-
- Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res. 2000;60:1388–93. - PubMed
-
- Mamlouk S, Wielockx B. Hypoxia-inducible factors as key regulators of tumor inflammation. Int J Cancer. 2013;132:2721–9. - PubMed
-
- McDonald DM, Baluk P. Significance of blood vessel leakiness in cancer. Cancer Res. 2002;62:5381–5. - PubMed
-
- Taylor CT, Colgan SP. Hypoxia and gastrointestinal disease. J Mol Med (Berl) 2007;85:1295–300. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials